Article Versions Notes

Jain V, Bage S, Dhiman N, Singh S, Yadav A, Brünnert D, Sawant DM, Goyal P. Relevance of EGFR-HER2 Dual Inhibition in Breast Cancer. Targets. 2026; 4(1):10. https://doi.org/10.3390/targets4010010

Jain, Vidhi, Saloni Bage, Nitisha Dhiman, Shaifali Singh, Arpana Yadav, Daniela Brünnert, Devesh M. Sawant, and Pankaj Goyal. 2026. "Relevance of EGFR-HER2 Dual Inhibition in Breast Cancer" Targets 4, no. 1: 10. https://doi.org/10.3390/targets4010010

Jain, V., Bage, S., Dhiman, N., Singh, S., Yadav, A., Brünnert, D., Sawant, D. M., & Goyal, P. (2026). Relevance of EGFR-HER2 Dual Inhibition in Breast Cancer. Targets, 4(1), 10. https://doi.org/10.3390/targets4010010